Several approaches have been proposed to limit these complications, such as autologous bone marrow transplantation at high-dose chemotherapy [30] or treatment with growth factors like G-CSF or Epo to alleviate neutropenia or to prevent anemia, respectively [31], [32]. The gene discussed is CSF3; the disease is Decreased total neutrophil count.